Marinus Pharmaceuticals, Inc. Common Stock

MRNS XS2399366108

💰
Capitalization
Small-cap

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
36
🙍
Insiders
10
Person Price Shares Total Published Completed
Manning Martha E
VP 		0.55
USD 		48,077
Sold 		26,442
USD 		07/02/2025 11/02/2025
Johnson Marvin
O 		0.55
USD 		7,101
Sold 		3,906
USD 		07/02/2025 11/02/2025
Braunstein Scott
CEO 		0.55
USD 		179,536
Sold 		98,745
USD 		14/08/2024 11/02/2025
Pfanstiel Steven
CFO 		0.55
USD 		62,470
Sold 		34,359
USD 		07/02/2025 11/02/2025
Hulihan Joseph
CMO 		0.55
USD 		55,570
Sold 		30,564
USD 		07/02/2025 11/02/2025
Ezickson Elan
O 		0.55
USD 		2,300
Sold 		1,265
USD 		07/02/2025 11/02/2025
Shafer Christina
CCO 		0.55
USD 		48,628
Sold 		26,745
USD 		07/02/2025 11/02/2025
Silverstein Christine Berni
O 		0.55
USD 		4,702
Sold 		2,586
USD 		07/02/2025 11/02/2025
Fischer Seth H. Z.
O 		0.55
USD 		2,300
Sold 		1,265
USD 		07/02/2025 11/02/2025
Mayleben Timothy M
O 		0.55
USD 		2,300
Sold 		1,265
USD 		07/02/2025 11/02/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Marinus Pharmaceuticals, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Braunstein Scott 5 305,569.15 61,113.83 16/02/2024 11/02/2025
Pfanstiel Steven 4 79,964.80 19,991.20 16/02/2024 11/02/2025
Hulihan Joseph 4 73,538.11 18,384.53 16/02/2024 11/02/2025
Shafer Christina 4 62,010.78 15,502.69 20/02/2024 11/02/2025
Manning Martha E 4 55,361.96 13,840.49 20/02/2024 11/02/2025
Mayleben Timothy M 5 11,471.35 2,294.27 07/02/2025 11/02/2025
Fischer Seth H. Z. 2 8,253.85 4,126.93 07/02/2025 11/02/2025
Silverstein Christine Berni 2 7,755.00 3,877.50 07/02/2025 11/02/2025
Johnson Marvin 3 7,738.90 2,579.63 21/01/2025 11/02/2025
Ezickson Elan 3 6,859.00 2,286.33 21/01/2025 11/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.